Evidence map›Paper›PMID 28818404›Full record

ReviewThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2017

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation.

Andrew E Gelman, Andrew J Fisher, Howard J Huang, Maher A Baz, Ciara M Shaver, Thomas M Egan, Micheal S Mulligan

Registry-linked trialAbstract readEditorialReview
In one paragraph

Review in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03598907 (Point-of-care), which is not on this map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03598907 terminatednot on this mapstarted 2018, after this paper: background citation

Point-of-care (POC) Approach to Management of Coagulopathy in Lung Transplantation Versus Standard Approach and Their Effect on Primary Graft Dysfunction (PGD), Randomized Controlled Study

TypeobservationalSponsorUniversity Hospital, MotolRan2018 to 2020Enrolled100ConditionsLung TransplantationArmsFresh frozen plasma
3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Trial
  2. Taming the Immaturity of Neutrophils Driving Injury in Lung Transplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Lung allograft dysbiosis associates with immune response and primary graft dysfunction.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
    Article
  11. Article
  12. Characteristics and Outcomes of 1500 Lung Transplantations in the Leuven Lung Transplant Program: Turning Past Lessons Into Tomorrow's Foundations.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  13. Article
  14. Nanoparticle targeting of neutrophil glycolysis prevents lung ischemia-reperfusion injury.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  15. MG53 mitigates warm ischemic lung injury in a murine model of transplantation.The Journal of thoracic and cardiovascular surgery · 2024
    Article
  16. Review
  17. Review
  18. Temporal correlation between postreperfusion complement deposition and severe primary graft dysfunction in lung allografts.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andrew E GelmanDepartment of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA. Electronic address: gelmana@wudosis.wustl.edu.
Andrew J FisherInstitute of Transplantation, Freeman Hospital and Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
Howard J HuangAnnette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, Texas, USA.
Maher A BazDepartments of Medicine and Surgery, University of Kentucky, Lexington, Kentucky, USA.
Ciara M ShaverDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Thomas M EganDepartment of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Micheal S MulliganDepartment of Surgery, Division of Cardiothoracic Surgery, University of Washington School of Medicine, Seattle, Washington, USA.

Funding

The Role of Neutrophils in Regulating Lung Transplant ToleranceP01AI116501 · NIAID · WASHINGTON UNIVERSITY · PI Andrew Eric Gelman · 2015 to 2026
$19.4M
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTIONR01HL094601 · NHLBI · WASHINGTON UNIVERSITY · PI Andrew Eric Gelman, Daniel Kreisel · 2009 to 2026
$6.9M
POSITRON EMISSION TOMOGRAPHIC IMAGING OF LUNG TRANSPLANTR01HL121218 · NHLBI · WASHINGTON UNIVERSITY · PI CHEN, DELPHINE L, GELMAN, ANDREW ERIC · 2014 to 2017
$2.8M
GRANULOPOIESIS REGULATION IN LUNG GRAFT ISCHEMIA-REPERFUSION INJURYR01HL113436 · NHLBI · WASHINGTON UNIVERSITY · PI GELMAN, ANDREW ERIC · 2013 to 2016
$1.5M
Department of Health 10/82/01NHLBI NIH HHS R01 HL094601NHLBI NIH HHS R01 HL113436NHLBI NIH HHS R01 HL121218NIAID NIH HHS P01 AI116501
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ConsensusSocieties, MedicalGlobal HealthGraft RejectionHeart-Lung TransplantationHumansIncidenceLungPrimary Graft Dysfunction

Identifiers

PMID28818404
PMCPMC5724959

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.